Study: Daily aspirin increases the risk for macular degeneration in seniors

Share this article:
Daily doses of aspirin in elderly adults can double the risk for developing the “wet” version of age-related macular degeneration (AMD), according to a new study.

The wet form of the eye disease refers to a more advanced version of the disorder, which is a leading cause of blindness in the elderly. Aspirin was not found to increase the risk for developing the more common but less-severe “dry” form of the disease. Many seniors take small doses of aspirin daily for pain, inflammation and to reduce the risk for heart disease.


To evaluate aspirin's effect on the disease, researchers from the Netherlands Institute for Neuroscience of the Royal Academy of Arts and Sciences, as well as the Academic Medical Center, analyzed data from 4,700 men and women across Europe. They caution that while more research is needed, they would advise patients with AMD not to use aspirin as a painkiller.

The study was published in the January issue of Ophthalmology .
Share this article:

More in News

Also in the news for August 22, 2014

Iowa's nursing homes lost, on average, 41% of their employees each year from 2010-2012 ... Researchers identify proteins necessary in wound healing ... More than 40% percent of SSDI recipients take opioid pain relievers, study says.

CMS: Many skilled nursing providers have poor Medicare certification and recertification practices

CMS: Many skilled nursing providers have poor Medicare ...

The rate of improper Medicare payments to skilled nursing facilities has increased largely due to issues with certification and recertification statements, according to a recently released government memorandum. The Centers ...

NY nursing home agrees to $2.2 million settlement in case of false documentation

NY nursing home agrees to $2.2 million settlement ...

Nursing home operator Ralex Services Inc. has agreed to a $2.2 million settlement in a whistleblower case involving forged documents at a facility in New Rochelle, New York.